SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-034831
Filing Date
2024-09-03
Accepted
2024-09-03 16:37:19
Documents
15
Period of Report
2024-09-03
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42185
  Complete submission text file 0001493152-24-034831.txt   267358

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE telo-20240903.xsd EX-101.SCH 3275
3 XBRL DEFINITION FILE telo-20240903_def.xml EX-101.DEF 29607
4 XBRL LABEL FILE telo-20240903_lab.xml EX-101.LAB 35952
5 XBRL PRESENTATION FILE telo-20240903_pre.xml EX-101.PRE 26664
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5170
Mailing Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131
Business Address 100 SE 2ND ST SUITE 2000 #1009 MIAMI FL 33131 786-396-6723
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

IRS No.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41952 | Film No.: 241274619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)